What’s New in Supportive Oncology for Patients with Breast Cancer

By Janet Abrahm, MD, FACP, FAAHPM, FASCO

October is Breast Cancer Awareness month, so this month’s newsletter will offer some insights, updates, and resources that I hope will be useful as you care for your patients with breast cancer.  If I have missed anything you use, please feel free to let me know.

Hot flashes
At ASCO 2025, results of the OASIS-4 trial were reported, showing that elinzanetant significantly decreased the frequency of moderate to severe hot flashes caused by endocrine therapy (i.e., aromatase inhibitors, SERMs, and estrogen receptor downregulators, or ovarian suppression) compared to placebo; common side effects of elinzanetant include headache, fatigue, somnolence and diarrhea. These are generally mild and disappear over time. Of note, however, is that 2.5% of patients discontinued elinzanetant due to these side effects or prolonged QT, bradycardia, or depression.  Use elinzanetant with caution, therefore, with other agents that prolong the QTc, such as ondansetron and olanzapine which are often prescribed to patients with breast cancer.

Fatigue
The 2024 ASCO-SIO guideline for fatigue in patients with breast cancer1 give STRONG recommendations to Exercise: aerobic + resistance training for patients on active therapy and survivors; Cognitive Behavioral Therapy: coping strategies for patients on active therapy and survivors with moderate to severe fatigue; and Mind-body practices: Mindfulness meditation and stress reduction techniques. They also recommend Tai Chi, and Giqong during therapy, and for survivors: yoga, acupressure, acupuncture, moxibustion (the burning of mugwort leaves). The guidelines recommend AGAINST modafinil, psychostimulants, and L-carnitine.

Sexual Dysfunction
A systematic review of women with breast cancer published in 20252 found that sexual dysfunction is highly prevalent, rising in one study from 17.5% at baseline to 73-86% after 6 months of hormone therapy.  The main problems are with desire, arousal, lubrication, orgasm, satisfaction and, for women who engage in penetrative sexual activity, dyspareunia. Women and men whether on therapy or off suffer from changes in body image, including weight gain and feeling disconnected from their bodies.

My September newsletter, The Sexual Health Conversation Patients Wish You’d Start: Insights from Dr. Sharon Bober contains a detailed discussion of sexual dysfunction in patients with cancer. As Dr. Bober explains, we do not have to FIX these problems, but we do need to ask, listen, and then refer patients to sexual health clinics, or to the relevant practitioner, for example a gynecologist, urologist, pelvic floor physical therapist, or social worker

Patients with breast cancer who have a vagina and find themselves in an estrogen-depleted state need to maintain the health of the vaginal tissue to prevent urinary tract infections. Low dose topical estrogens (e.g. tablets) in the vagina twice a week can maintain the tissues, decrease dyspareunia and lower the incidence of urinary tract infections.  Additional therapy for dyspareunia includes lubricants and moisturizers.

How Integrative Therapy Can Help
Integrative therapies are also helpful for a variety of other symptoms experienced by patients with breast cancer.  For clarity, I’ve created a chart of the 2024 ASCO integrative therapy Guideline’s recommendations.3

References

  1. Mustian K, Lacchetti C, Zick S, Bower JE. Management of Fatigue in Adult Survivors of Cancer: American Society of Clinical Oncology – Society for Integrative Oncology (ASCO-SIO) Guideline Update Clinical Insights. JCO Oncol Pract. 2024 Dec;20(12):1575-1579. doi: 10.1200/OP.24.00372. Epub 2024 Jul 2. PMID: 38954779.
  2. Rodrigues-Machado N, Bonfill-Cosp X, Quntana M, et al. Sexual dysfunction in women with breast cancer: a systematic review. Support Care Cancer 2025;33:332
  3. Gowin K, Muminovic M, Zick SM, Lee RT, Lacchetti C, Mehta A. Integrative Therapies in Cancer Care: An Update on the Guidelines. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e431554. doi: 10.1200/EDBK_431554. PMID: 38820485.

Additional Resources

Organizations for Breast Cancer Patients and their Partners and Families

Several organizations exist to help patients with breast cancer and their partners and families. ASCO is partnering with the American Cancer Society to provide such support.   Here are ASCO’s website and the websites of a few others you can recommend (in alphabetical order): 

Websites for Special populations

Other Resources On My Website

homepage-collage-2

Join Dr. Abrahm’s newsletter,
“And What Else...?”

oncology supportive care

Supportive and Palliative Care Resources

A primary objective of this website is to offer the most helpful and up to date resources in palliative care for oncologists and palliative care clinicians. From her ongoing practice of palliative care and the extensive research behind the 4th edition of her book, Dr. Abrahm has created and curated content in the four following subject areas. The content will be updated regularly so please continue to check back.

oncology supportive care

About Dr. Abrahm

Janet Abrahm, MD is Professor of Medicine at Harvard Medical School. She is among the founders of Palliative Care in the United States and the author of four comprehensive books on supportive and palliative care for patients with cancer. Dr. Abrahm is a former practicing oncologist who created the Palliative Care Service at Dana-Farber Cancer Institute over 20 years’ ago. She is an award-winning clinician and educator and continues to practice palliative care at Dana Farber.

Learn More

oncology supportive care

Dr. Abrahm's Book

Dr. Abrahm is the author of four comprehensive editions 
on supportive and palliative care for patients with cancer, the first published in 2000 and the latest in 2022.

Her extensive work offers oncologists and other oncology and palliative care clinicians a place to turn to find the most up-to-date evidence-based practices, resources, and practical advice on how to care for patients across the full range of issues they will experience during their illness.

Learn More